Veracyte Announces Preliminary Fourth Quarter and Full-Year 2020 Financial ResultsBusiness Wire • 02/03/21
Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid CancerBusiness Wire • 12/22/20
Veracyte: A Strong Recovery Turning Into Strong Growth In The Midst Of A PandemicSeeking Alpha • 12/22/20
Veracyte Announces ISO 13485:2016 Certification for Its In Vitro Diagnostics Quality Management SystemBusiness Wire • 12/21/20
Veracyte Announces New Preliminary Data for Its In-Development Lung Cancer Portfolio TestsBusiness Wire • 12/16/20
Veracyte Announces Expansion of Collaboration with the Lung Cancer Initiative at Johnson & JohnsonBusiness Wire • 12/15/20
Veracyte to Participate in Piper Sandler 32nd Annual Virtual Healthcare ConferenceBusiness Wire • 11/23/20
Veracyte, Inc. (VCYT) CEO Bonnie Anderson on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/03/20
Veracyte Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test's Genomic Underpinning Drives Prognostic PerformanceBusiness Wire • 10/30/20
Analysts Estimate Veracyte (VCYT) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/26/20
Veracyte Announces Publication of Manuscript Describing Scientific Rigor Behind Next-Generation Percepta Genomic Sequencing ClassifierBusiness Wire • 10/22/20
Veracyte Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST Annual Meeting 2020Business Wire • 10/19/20
Veracyte Announces Two Presentations to Be Shared at CHEST Annual Meeting 2020Business Wire • 10/14/20
Veracyte Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid ServicesBusiness Wire • 09/24/20
Veracyte Announces Initiation of Consensus Study Exploring Medical Utility of Multiple Breast Cancer Genomic TestsBusiness Wire • 09/11/20
Veracyte Named a San Francisco Bay Area “Top Workplace” for Seventh Consecutive YearBusiness Wire • 08/24/20
Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesBusiness Wire • 08/07/20